Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C11H12NO4PS2 |
| Molecular Weight | 317.321 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COP(=S)(OC)SCN1C(=O)C2=CC=CC=C2C1=O
InChI
InChIKey=LMNZTLDVJIUSHT-UHFFFAOYSA-N
InChI=1S/C11H12NO4PS2/c1-15-17(18,16-2)19-7-12-10(13)8-5-3-4-6-9(8)11(12)14/h3-6H,7H2,1-2H3
| Molecular Formula | C11H12NO4PS2 |
| Molecular Weight | 317.321 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Phosmet is a non-systemic, organophosphate insecticide used on both plants and animals. Phosmet is mainly used on apple trees for control of coddling moth, though it is used on a wide range of fruit crops, ornamentals and vines for the control of aphids, suckers, mites and fruit flies. Phosmet is a moderately potent cholinesterase inhibitor.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10509429
Curator's Comment: Phosmet produced severe cholinergic signs associated with > 80% inhibition of brain AchE at 24 h in in adult hens.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Sarcoptes scabiei Sources: https://www.ncbi.nlm.nih.gov/pubmed/8128575 |
|||
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8128575 |
Preventing | Prolate I-E Approved UseA beef and non-lactating dairy cattle insecticide for the control of lice, cattle ticks, southern cattle ticks, winter ticks, lone star ticks, gulf coast ear ticks, hornflies, sarcoptic mange and scabies mites and a swine insecticide for control of lice and sarcoptic mange. Launch Date1991 |
Overview
| CYP3A4 | CYP2C9 | CYP2D6 | hERG |
|---|---|---|---|
OverviewOther
| Other Inhibitor | Other Substrate | Other Inducer |
|---|---|---|
Drug as perpetrator​
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
| no [IC50 >100 uM] | ||||
Page: 353.0 |
no | |||
| no | ||||
Page: 59.0 |
no | |||
| no | ||||
| no | ||||
Page: 81.0 |
no | |||
| yes [IC50 0.4365 uM] | ||||
| yes [IC50 0.7762 uM] | ||||
| yes [IC50 10.4 uM] | ||||
Page: 12.0 |
yes [IC50 15.4871 uM] | |||
Page: 4.0 |
yes [IC50 2.4545 uM] | |||
| yes [IC50 42 uM] | ||||
Page: 8.0 |
yes [IC50 6.9178 uM] | |||
Page: 9.0 |
yes [IC50 7.7507 uM] | |||
| yes [IC50 7.9 uM] | ||||
| yes | ||||
| yes |
Drug as victim
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
| major [Km 1.496 uM] | ||||
| minor [Km 16.01 uM] | ||||
| minor [Km 340.7 uM] | ||||
Page: 346 | 354 |
no | |||
| yes [Km 1.288 uM] | ||||
| yes [Km 16.44 uM] | ||||
| yes [Km 2.195 uM] | ||||
| yes [Km 229.7 uM] | ||||
| yes [Km 4.01 uM] | ||||
| yes |
Tox targets
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 206.0 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Spectroscopic characterization and structural modeling of prolamin from maize and pearl millet. | 2004-07 |
|
| Polyhydroxyalkanoate (PHA) granule formation in Ralstonia eutropha cells: a computer simulation. | 2004-06 |
|
| Wavefront technology in cataract surgery. | 2004-02 |
|
| A finite B-spline basis set for accurate diatomic molecule calculations. | 2004-02 |
|
| Predicted electric field near small superconducting ellipsoids. | 2004-01-09 |
|
| Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma. | 2004-01-01 |
|
| Interactions of the neurotoxin vipoxin in solution studied by dynamic light scattering. | 2004-01 |
|
| Organophosphorous and organochlorine pesticides affect human placental phosphoinositides metabolism and PI-4 kinase activity. | 2004 |
|
| Solution conformation of a nitrobenzoxadiazole derivative of the polyene antibiotic nystatin: a FRET study. | 2003-12-05 |
|
| Clinical significance of 3D reconstruction of arteriovenous malformation using digital subtraction angiography and its modification with CT information in stereotactic radiosurgery. | 2003-12-01 |
|
| The interobserver reliability of ovarian volume measurement is improved with three-dimensional ultrasound, but dependent upon technique. | 2003-12 |
|
| Microsomal transformation of organophosphorus pesticides by white rot fungi. | 2003-12 |
|
| The magnetic lead field theorem in the quasi-static approximation and its use for magnetoencephalography forward calculation in realistic volume conductors. | 2003-11-21 |
|
| Spherical aberration after laser in situ keratomileusis and photorefractive keratectomy. Clinical results and theoretical models of etiology. | 2003-11 |
|
| Vibration of prolate spheroidal shells with shear deformation and rotatory inertia: axisymmetric case. | 2003-11 |
|
| Acoustic backscattering by Hawaiian lutjanid snappers. 1. Target strength and swimbladder characteristics. | 2003-11 |
|
| The ontogenetic scaling of hydrodynamics and swimming performance in jellyfish (Aurelia aurita). | 2003-11 |
|
| Structural and functional characterization of the human NBC3 sodium/bicarbonate co-transporter carboxyl-terminal cytoplasmic domain. | 2003-10-28 |
|
| Biomolecular stress-sensitive gauges: surface-mediated immobilization of mechanosensitive membrane protein. | 2003-10-22 |
|
| Photolysis experiments on phosmet, an organophosphorus insecticide. | 2003-09-24 |
|
| Morphology-dependent resonances of nearly spherical particles in random orientation. | 2003-09-20 |
|
| A comparison of CT scan to transrectal ultrasound-measured prostate volume in untreated prostate cancer. | 2003-09-01 |
|
| Effect of electric field induced transmembrane potential on spheroidal cells: theory and experiment. | 2003-09 |
|
| Management of insecticide resistance in Oriental fruit moth (Grapholita molesta; Lepidoptera: Tortricidae) populations from Ontario. | 2003-08 |
|
| The shape parameter of liposomes and DNA-lipid complexes determined by viscometry utilizing small sample volumes. | 2003-08 |
|
| A new radionuclide approach for the quantification of left ventricular volumes: the 'geometric count based' method. | 2003-08 |
|
| A general gel layer model for the transport of colloids and macroions in dilute solution. | 2003-07-01 |
|
| Bacteriophage phi29 scaffolding protein gp7 before and after prohead assembly. | 2003-07 |
|
| Two-dimensional packing in prolate granular materials. | 2003-05 |
|
| Effect of pesticide use in fruit production orchards on shallow ground water. | 2003-05 |
|
| The use of a new miniature cryoprobe for ablation of bone tissue: in vivo assessment of the probe and application of the method to bone in a sheep model. | 2003-04-22 |
|
| The primary electroviscous effect of prolate silica sols. | 2003-04-15 |
|
| Trifluoperazine effects on anionic and zwitterionic micelles: a study by small angle X-ray scattering. | 2003-04-15 |
|
| The effects of acute pesticide exposure on neuroblastoma cells chronically exposed to diazinon. | 2003-03-14 |
|
| Near-field calculations for a rigid spheroid with an arbitrary incident acoustic field. | 2003-03 |
|
| Mathematical model of corneal surface smoothing after laser refractive surgery. | 2003-03 |
|
| New shape isomer in the self-conjugate nucleus 72Kr. | 2003-02-28 |
|
| The primary electroviscous effect, free solution electrophoretic mobility, and diffusion of dilute prolate ellipsoid particles (minor axis = 3 nm) in monovalent salt solution. | 2003-02-15 |
|
| Cataract surgery in patients with prior refractive surgery. | 2003-02 |
|
| Study of corneal topographic patterns with single continuous suturing techniques in penetrating keratoplasty. | 2003-01 |
|
| The importance of prostatic measuring by transrectal ultrasound in surgical management of patients with clinically benign prostatic hyperplasia. | 2003 |
|
| A characterization of the lumenal region of human tapasin reveals the presence of two structural domains. | 2002-12-10 |
|
| Prospective randomized trial of an anterior surface modified prolate intraocular lens. | 2002-12-03 |
|
| A new intraocular lens design to reduce spherical aberration of pseudophakic eyes. | 2002-12-03 |
|
| Contrast-assisted destruction-replenishment ultrasound for the assessment of tumor microvasculature in a rat model. | 2002-12 |
|
| Backbone dynamics of the cytotoxic ribonuclease alpha-sarcin by 15N NMR relaxation methods. | 2002-12 |
|
| Shapes of phospholipid [correction of phosholipid] vesicles with beadlike protrusions. | 2002-12 |
|
| Geodesic chaos around quadrupolar deformed centers of attraction. | 2002-10 |
|
| Three-axis ellipsoidal fitting of videokeratoscopic height data after penetrating keratoplasty. | 2002-06 |
|
| [Pollen morphology of bee plants in Changbai Mountain area]. | 2001-04 |
Patents
Sample Use Guides
Cattle and swine: Dip Spray
Use at the following dilutions of drug: water
- Use for the control of grubs; apply dips at 1:60, pour-ons at 1:2, and sprays at 1:49.
- Use for the control of lice; apply dips at 1:60, pour-ons at 1:2 or 1:5, and sprays at 1:49 or 1:100.
- Use for the control of horn flies; apply dips at 1:60 and sprays at 1:49 or 1:100.
- Use for the control of cattle ticks; apply dips at 1:60 or 1:240 and sprays at 1:49.
- Use for the control of Southern cattle ticks; apply dips at 1:60 or 1:240 and sprays at 1:49.
- Use for the control of scabies mites; apply dips at 1:60.
- Use for the control of Lone Star ticks; apply dips at 1:60 and sprays at 1:49 or 1:100.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22265773
Phosmet (1-1000 uM) reduced cell viability and induced cellular injury in JEG-3 cells. After 24 h of incubation
with Phosmet at 10 or 100 uM, 25.4% and 29.6% of annexin-V positive
JEG-3 cells could be detected, respectively.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:11:25 GMT 2025
by
admin
on
Mon Mar 31 18:11:25 GMT 2025
|
| Record UNII |
VN04LI540Y
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QP53BB03
Created by
admin on Mon Mar 31 18:11:25 GMT 2025 , Edited by admin on Mon Mar 31 18:11:25 GMT 2025
|
||
|
CFR |
21 CFR 524.1742
Created by
admin on Mon Mar 31 18:11:25 GMT 2025 , Edited by admin on Mon Mar 31 18:11:25 GMT 2025
|
||
|
WHO-VATC |
QP53AF06
Created by
admin on Mon Mar 31 18:11:25 GMT 2025 , Edited by admin on Mon Mar 31 18:11:25 GMT 2025
|
||
|
NCI_THESAURUS |
C737
Created by
admin on Mon Mar 31 18:11:25 GMT 2025 , Edited by admin on Mon Mar 31 18:11:25 GMT 2025
|
||
|
EPA PESTICIDE CODE |
59201
Created by
admin on Mon Mar 31 18:11:25 GMT 2025 , Edited by admin on Mon Mar 31 18:11:25 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
12901
Created by
admin on Mon Mar 31 18:11:25 GMT 2025 , Edited by admin on Mon Mar 31 18:11:25 GMT 2025
|
PRIMARY | |||
|
DTXSID5024261
Created by
admin on Mon Mar 31 18:11:25 GMT 2025 , Edited by admin on Mon Mar 31 18:11:25 GMT 2025
|
PRIMARY | |||
|
C76877
Created by
admin on Mon Mar 31 18:11:25 GMT 2025 , Edited by admin on Mon Mar 31 18:11:25 GMT 2025
|
PRIMARY | |||
|
phosmet
Created by
admin on Mon Mar 31 18:11:25 GMT 2025 , Edited by admin on Mon Mar 31 18:11:25 GMT 2025
|
PRIMARY | |||
|
VN04LI540Y
Created by
admin on Mon Mar 31 18:11:25 GMT 2025 , Edited by admin on Mon Mar 31 18:11:25 GMT 2025
|
PRIMARY | |||
|
PHOSMET
Created by
admin on Mon Mar 31 18:11:25 GMT 2025 , Edited by admin on Mon Mar 31 18:11:25 GMT 2025
|
PRIMARY | |||
|
732-11-6
Created by
admin on Mon Mar 31 18:11:25 GMT 2025 , Edited by admin on Mon Mar 31 18:11:25 GMT 2025
|
PRIMARY | |||
|
211-987-4
Created by
admin on Mon Mar 31 18:11:25 GMT 2025 , Edited by admin on Mon Mar 31 18:11:25 GMT 2025
|
PRIMARY | |||
|
38786
Created by
admin on Mon Mar 31 18:11:25 GMT 2025 , Edited by admin on Mon Mar 31 18:11:25 GMT 2025
|
PRIMARY | |||
|
1734
Created by
admin on Mon Mar 31 18:11:25 GMT 2025 , Edited by admin on Mon Mar 31 18:11:25 GMT 2025
|
PRIMARY | |||
|
DB11448
Created by
admin on Mon Mar 31 18:11:25 GMT 2025 , Edited by admin on Mon Mar 31 18:11:25 GMT 2025
|
PRIMARY | |||
|
D010706
Created by
admin on Mon Mar 31 18:11:25 GMT 2025 , Edited by admin on Mon Mar 31 18:11:25 GMT 2025
|
PRIMARY | |||
|
300000029414
Created by
admin on Mon Mar 31 18:11:25 GMT 2025 , Edited by admin on Mon Mar 31 18:11:25 GMT 2025
|
PRIMARY | |||
|
m8718
Created by
admin on Mon Mar 31 18:11:25 GMT 2025 , Edited by admin on Mon Mar 31 18:11:25 GMT 2025
|
PRIMARY | Merck Index | ||
|
CHEMBL1481873
Created by
admin on Mon Mar 31 18:11:25 GMT 2025 , Edited by admin on Mon Mar 31 18:11:25 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |